Clinical Trials Browser

Has results × Urogenital Neoplasms × Genitourinary × Clear all

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT03933826 2025-11-04

CISTO

Active not recruiting

570 enrolled 27 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Diseases

NCT03344757 2025-09-11

Health Gatherings - For Your Health After Cancer

Phase NA Completed

188 enrolled 19 charts

Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT03081858 2025-06-27

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

Phase 1/2 Completed

15 enrolled 16 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT05288166 2025-06-27

CYCLONE 3

Phase 3 Active not recruiting

925 enrolled 12 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Urogenital Neoplasms

NCT04578132 2025-04-01

SOGUGCOVID

Completed

410 enrolled 29 charts

Genitourinary

COVID-19, Kidney Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms

NCT01540994 2025-01-16

Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer

Phase NA Completed

12 enrolled 7 charts

Genitourinary

Genital Neoplasms, Male, Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms

NCT00946881 2024-02-07

Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

Phase 1/2 Completed

30 enrolled 12 charts

Genitourinary

Genital Diseases, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT03636256 2023-08-14

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Phase 1/2 Completed

36 enrolled 18 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urogenital Neoplasms, Urologic Neoplasms

NCT04221828 2022-03-29

Trial of NanoPac Focal Therapy for Prostate Cancer

Phase 2 Terminated

1 enrolled 5 charts

Genitourinary

Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

NCT03490032 2020-11-17

PROfind

Phase 1/2 Completed

30 enrolled 30 charts

Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT02060370 2020-02-27

Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)

Phase 2 Completed

60 enrolled 13 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms

NCT03077659 2019-08-20

Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer

Phase 2 Completed

16 enrolled 12 charts

Genitourinary

Genital Neoplasms, Male, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT01310803 2017-10-05

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Phase 3 Terminated

1 enrolled 5 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT01200992 2017-08-24

EMBARC-RF

Phase 3 Terminated

84 enrolled 7 charts

Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Mycobacterium Infections, Neoplasm Recurrence, Local, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT01431391 2017-05-30

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Phase 2 Completed

68 enrolled 11 charts

Genitourinary

Adenocarcinoma, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT00631371 2016-04-27

INTORACT

Phase 3 Completed

791 enrolled 11 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms

NCT00753415 2015-03-17

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Phase 1 Completed

37 enrolled 10 charts

BreastDermatologicEndocrineGastrointestinalGenitourinaryNETThoracic

Adenocarcinoma, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Breast Diseases, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Genital Diseases, Male, Intestinal Neoplasms, Kidney Diseases, Kidney Neoplasms, Melanoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Prostatic Diseases, Prostatic Neoplasms, Skin Diseases, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Colorectal Neoplasms, Neuroectodermal Tumors, Nevi and Melanomas, Neuroendocrine Tumors

NCT00147238 2012-08-07

A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast

Phase NA Terminated

10 enrolled 3 charts

Genitourinary

Urinary Bladder Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms

NCT00460798 2010-11-16

SUNIKA

Completed

356 enrolled 8 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Urogenital Neoplasms

Clinical Trials

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

CISTO

Health Gatherings - For Your Health After Cancer

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

CYCLONE 3

SOGUGCOVID

Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer

Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Trial of NanoPac Focal Therapy for Prostate Cancer

PROfind

Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)

Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

EMBARC-RF

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

INTORACT

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast

SUNIKA